Vesticap - instructions for use, analogs, reviews and release forms (capsules or tablets 8 mg, 16 mg and 24 mg) drugs for the treatment of tinnitus and Meniere's disease in adults, children and pregnancy

In this article, you can read the instructions for using the drug Vestap. There are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors specialists on the use of Vesticap in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Vesticap in the presence of existing structural analogues. Use to treat Meniere's disease and tinnitus in adults, children, as well as during pregnancy and lactation.

Vestap - a synthetic analog of histamine.It acts like histamine, mainly on histamine H1 receptors. It causes the expansion of precapillaries, in particular, facilitates microcirculation in the labyrinth. In addition, betahistine regulates the pressure of the endolymph in the labyrinth and cochlea, leading to a clinical improvement in the dizziness of various etiologies. Reduces the frequency and intensity of dizziness, reduces tinnitus, helps improve hearing in cases of its decline. Increases the tone of smooth muscles of the bronchi, gastrointestinal tract. May cause increased secretion of gastric juice.

Pharmacokinetics

After ingestion of betahistine dihydrochloride (the active substance of the drug Vesticap) quickly and almost completely absorbed from the digestive tract. Virtually completely eliminated from the body with urine within 24 hours.

Indications

• Meniere's disease;
• syndromes characterized by dizziness, tinnitus and / or progressive hearing loss, incl. edema of the labyrinth of the inner ear;
• vestibular and labyrinthine disorders (including dizziness, noise and pain in the ears, headache, nausea, vomiting, hearing loss);
• vestibular neuritis;
• labyrinthite;
• benign positional dizziness (including after neurosurgical operations);
• vertebrobasilar insufficiency;
• post-traumatic encephalopathy;
• atherosclerosis of cerebral vessels (as part of complex therapy).

Forms of release

Capsules 8 mg, 16 mg and 24 mg (forms in the form of tablets do not exist).

Instructions for use and dosing regimen

Single dose - 8-16 mg, the frequency of reception - 3 times a day. Treatment is long.

Side effect

• nausea;
• feeling of heaviness in the epigastrium;
• skin rash;
• itching;
• hives.

Contraindications

• pheochromocytoma;
• peptic ulcer of the stomach and duodenum in the phase of exacerbation;
• bronchial asthma;
• 1 trimester of pregnancy;
• increased sensitivity to betagistin.

Application in pregnancy and lactation

It is not recommended to use in the first trimester of pregnancy and during lactation. With caution should be used in the 2nd and 3rd trimesters of pregnancy.

Use in children under 12 years of age

Use with caution in children.

special instructions

It should be noted that the desired clinical effect is achieved after several months of treatment.

With dyspeptic symptoms, Vesticap is recommended during or after a meal.

Drug Interactions

Antihistamines with simultaneous intake reduce the effect of betahistine.

Analogues of the drug Vestap

Structural analogs for the active substance:

• Asnithon;
• Betaver;
• Betagistin;
• Betagistin hydrochloride;
• Betahistine dihydrochloride;
• Betaserc;
• Betacentrine;
• Vasoserk;
• Vestibo;
• Denoise;
• The micrometer;
• Tagist.

Similar medicines:

Other medicines: